Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.7T | 4.1T | 2.1T | 2.7T |
Cost of revenue | 1.3T | 2.2T | 1.1T | 1.5T |
Gross profit | 1.4T | 1.8T | 973.7B | 1.3T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 202.5B | 246.0B | 195.6B | 180.1B |
Other operating expenses | 14.0B | 31.0B | 40.2B | 16.5B |
Operating income | 935.4B | 1.4T | 466.8B | 803.5B |
Non operating interest income | ||||
Income | 121.7B | 140.9B | 143.0B | 124.7B |
Expense | 139.4B | -309.3B | 293.1B | 257.9B |
Other income expense | — | — | — | — |
Pretax income | 672.5B | 764.9B | 476.7B | 614.5B |
Tax provision | 3.9B | -157.7B | 203.8B | 9.7B |
Net income | 668.6B | 922.6B | 273.0B | 604.8B |
Basic EPS | 36 | — | — | — |
Diluted EPS | 36 | — | — | — |
Basic average shares | 18.5B | — | — | — |
Diluted average shares | 18.5B | — | — | — |
EBITDA | 837.3B | 494.2B | 810.6B | 910.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | -8.2B | -73.4B | -25.0B | -59.0B |
Preferred stock dividends | 0 | 0 | 0 | 0 |